The fundamental role of inflammation in cardiovascular disease (CVD) has prompted
interest in numerous biomarkers that detect subclinical levels of inflammation. Soluble …

This review summarizes the published literature referring to the use and validity of the
biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the …

High-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-
proBNP) strongly predict heart failure (HF) in the general population. However, the …

Consistent reports indicate that hypertension is a particularly common finding in black
populations. Hypertension occurs at younger ages and is often more severe in terms of …

Background Soluble urokinase plasminogen activator receptor (suPAR) is an emerging
marker of cardiovascular disease burden. Appropriate assessment of assay performance …

Background Elevated inflammatory markers such as C-reactive protein (CRP) and
interleukin-6 (IL-6) are well-known risk factors for cardiovascular mortality. The less familiar …

Objective The soluble urokinase plasminogen activator receptor (suPAR) has potential as a
prognosis and severity biomarker in several inflammatory and infectious diseases. In a …

Objective and Design The soluble urokinase plasminogen activator receptor (suPAR) has
been recently recognized as a potential biological marker of various disease states, but the …

A loss of arterial elasticity increases the risk for cardiovascular events. Oxidative injury to the
vessel wall may be one of the underlying mechanisms influencing arterial elasticity. We …

The balance between dilatory and constrictive factors is important as it keeps blood vessels
in a homeostatic state. However, altered physiological processes as a result of obesity …